In conclusion, the present study shows that 5-cholestenone may have an NFκB inhibitory effect, suggesting that a diet supplemented with 5-cholestenone may potentially alleviate obesity-induced metabolic disorders through its action as an anti-inflammatory agent in the metabolic syndrome. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.